MedTrace Logo

Study to Evaluate Efficacy and Safety of PreLipid® on Subjects With Higher Than Normal Blood Lipid Levels

NCT02187757 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2015-05-15

No results posted yet for this study

Summary

Study to evaluate Efficacy and Safety of PreLipid® on subjects with higher than normal blood lipid levels

Conditions

Interventions

DIETARY_SUPPLEMENT

Study Dietary Supplement (Prelipid 500 mg capsules)

Study Dietary Supplement (PreLipid 600 mg capsules) will be given to subjects twice daily 30 mins before food for 90 days along with lifestyle modification.

DIETARY_SUPPLEMENT

Placebo

Sponsors & Collaborators

  • Abbott

    collaborator INDUSTRY

  • PreEmptive Meds, Pvt. Ltd

    lead INDUSTRY

Principal Investigators

  • Ravi Kasliwal, MD, DM, FIMSA · Medanta, The Medicity, India

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2014-11-30
Completion
2014-11-30

Countries

  • India

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02187757 on ClinicalTrials.gov